Integration of results on diabetes into international analyses and reports

The article published in the Lancet shows the global temporal development of diabetes prevalence and medical diabetes treatment over time with data from 200 countries and territories. The number of people with diabetes in the adult population worldwide has risen from 630 million in 1990 to 828 million in 2022, with an estimated number of around 8 million in Germany in 2022. While in most countries, especially in those with low and middle income, the diabetes treatment has not increased at all or has not increased sufficiently compared to the increase in diabetes prevalence, Germany shows a considerable increase in the proportion with diabetes treatment and a comparatively small increase in diabetes prevalence. The results for Germany are also visualized in a country fact sheet.

The article published in the Journal of Health Monitoring is based on information on key health indicators for more than 300,000 adults from the general population in Europe. It shows that in Germany, the self-reported 12-month prevalence of diabetes and the proportion of people with diabetes who reported moderate or severe health-related limitations in everyday activities is higher than the average of the 29 European countries included. In contrast, the proportion of people with diabetes who rated their general health as very good or good was higher in Germany than the European average.

The WHO report presents the five global diabetes targets to strengthen the prevention and control of diabetes. Various approaches and data sources exist in the WHO European Region to measure progress towards these goals. For Germany, diabetes surveillance enables four of these five targets to be explicitly measured through data from the RKI health examination surveys. The two targets 80% of people with diabetes are diagnosed and 80% of people with diagnosed diabetes have good control of glycaemia were already achieved or almost achieved in 2010, while the two targets 80% of people with diagnosed diabetes have good control of blood pressure and 60% of people with diabetes of 40 years or older receive statins were not yet achieved. The last target of 100% of people with type 1 diabetes having access to affordable insulin treatment and blood glucose self-monitoring can also be assumed to have been achieved due to the corresponding services provided by the German healthcare system.